An Integrated Program in a Pandemic: Johns Hopkins Radiation Oncology Department
Jean L. Wright(University of North Carolina at Chapel Hill), Akila Viswanathan(Johns Hopkins University), S. Han-Oh(Johns Hopkins University), Marikki Laiho(Johns Hopkins University), Amol Narang(Johns Hopkins University), Harry Quon(Johns Hopkins University), Lawrence Kleinberg(Johns Hopkins University), Stephen Greco(Johns Hopkins University), Matthew Ladra(Johns Hopkins University), Victoria Croog(Johns Hopkins University), R Rodríguez González(Johns Hopkins University), F. Asrari(Johns Hopkins Hospital), Daniel Y. Song(Johns Hopkins University), Curtiland Deville(Johns Hopkins University), Jennifer Vogel(Johns Hopkins University), Jeffrey Meyer(Johns Hopkins University), Christina Tsien(McGill University Health Centre), Sara R. Alcorn(University of Minnesota), J. Wieworka(Johns Hopkins University), Phuoc T. Tran(University of Chicago Medical Center), Ana P. Kiess(Johns Hopkins University), Todd McNutt(Johns Hopkins University), Lan Lin(Johns Hopkins University), Russel K. Hales(Johns Hopkins University), Amanda J. Walker(National Cancer Institute), Roberta Anderson(Johns Hopkins University), Kristin J. Redmond(Johns Hopkins University), R. Voong(Johns Hopkins University), B.R. Page(Johns Hopkins University)
Cited by 17
Related Papers
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models
|Clinical Cancer Research|2007|776
Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline
|Practical Radiation Oncology|2018|615
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer
|Cell|2017|521
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
|Science Translational Medicine|2015|502